Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. White MG, Schulte JJ, Xue L, Berger Y, et al. Br J Cancer 2021;124:564-566.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

White MG, Schulte JJ, Xue L, Berger Y, et al. Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer 2021;124:564-566.
PMID: 33100328